David Wilson, BSc, MBA

David Wilson, BSc, MBA

Consultant

David has over 25 years of international experience in business development, marketing, and sales management, with a focus on the in vitro diagnostics industry. He has hands-on experience in international marketing, strategy development, licensing, international sales channel management, product/technology assessments, and regulatory affairs. David has held senior positions in private and public organizations, including both global corporations and a VC-funded start-up and has extensive knowledge of, and networks in, domestic and international IVD markets. He is currently leading the global expansion for a US-based medtech business entering new markets outside North America, advising a life science tools business on M&A strategy, and recently joined the Board of a university-spin out preparing for their Series A funding. Previously, David has led the Dx consulting practice at Alacrita focused on developing early stage Dx businesses, and served as VP Commercial Operations, Europe for Molecular Detection Inc., a VC-funded molecular diagnostics start-up with a focus on assays for hospital acquired infections based in Wayne, PA. Before that he spent 12 years with Genzyme Corporation in Diagnostic Products and Molecular Oncology, and three years with Boehringer Mannheim Diagnostics. David has a BSc in Biochemistry with Microbiology from the University of St Andrews, Scotland and University of California at Santa Barbara, and an MBA from the Open University Business School.

We are a specialist medical device consultancy consisting of industry experts with long and successful track records in commercialising medical device products. We have broad functional and sector experience, and would welcome an opportunity to discuss with you any challenge relating to creating sustainable value from medical technologies.